EVA Pharma is participating as a sponsor for the first time at the European Association for the Study of Diabetes’ (EASD) 2022 Annual Meeting, which will be held in Stockholm, Sweden, from 19 to 23 September. 

The EASD holds its Annual Meeting in a different European city each year, with more than 15,000 delegates from over 130 countries attending. The scientific program at this year’s 58th Annual Meeting includes more than 1,200 talks and presentations on the latest results in diabetes research by leading experts in the field.